Abcam (ABC)

Sector:

Pharma and Biotech

Index:

FTSE AIM 50

1,145.00p
   
  • Change Today:
      23.00p
  • 52 Week High: 1,750.00
  • 52 Week Low: 1,049.00
  • Currency: UK Pounds
  • Shares Issued: 228.94m
  • Volume: 117,147
  • Market Cap: £2,621.37m
  • RiskGrade: 134

Financial Analysis

Select chart: EPS | Dividend | Revenue

Key Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
30-Jun-18 233.20 69.10 32.70p 40.8 1.5 +27% 12.00p 0.9%
30-Jun-19 259.90 56.40 32.90p 44.8 44.8 +1% 12.13p 0.8%
30-Jun-20 260.00 8.40 16.70p 79.8 n/a -49% 3.55p 0.3%
30-Jun-21 297.70 25.40 13.70p 100.8 n/a -18% n/a 0.0%
31-Dec-21 462.90 20.30 65.86p 26.3 0.1 +381% n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Forecasts

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-22 383.12 82.38 29.07p 39.4 n/a -56% 1.05p 0.1%
31-Dec-23 428.77 106.80 36.41p 31.4 1.2 +25% 1.31p 0.1%

Copyright © 2022 FactSet Research Systems Inc. All rights reserved.

Price / Earnings Data

5 Yr High 5 Yr Low 5 Yr Avg Curr / Avg
Latest 40.80 26.31 58.51 0.30

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

IFRS Changes - Find Out More

Find out about IFRS and how this affects the financial infomation for all UK companies.

Abcam Market Data

Currency UK Pounds
Share Price 1,145.00p
Change Today 23.00p
% Change 2.05 %
52 Week High 1,750.00
52 Week Low 1,049.00
Volume 117,147
Shares Issued 228.94m
Market Cap £2,621.37m
RiskGrade 134

Abcam Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
92.66% below the market average92.66% below the market average92.66% below the market average92.66% below the market average92.66% below the market average
89.29% below the sector average89.29% below the sector average89.29% below the sector average89.29% below the sector average89.29% below the sector average
Price Trend
63.71% below the market average63.71% below the market average63.71% below the market average63.71% below the market average63.71% below the market average
7.94% above the sector average7.94% above the sector average7.94% above the sector average7.94% above the sector average7.94% above the sector average
Income
97.19% below the market average97.19% below the market average97.19% below the market average97.19% below the market average97.19% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average
Growth
96.50% above the market average96.50% above the market average96.50% above the market average96.50% above the market average96.50% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average

What The Brokers Say

Strong Buy 4
Buy 1
Neutral 8
Sell 0
Strong Sell 0
Total 13
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Abcam Dividends

  Latest Previous
  Interim Final
Ex-Div 19-Mar-20 07-Nov-19
Paid 17-Apr-20 29-Nov-19
Amount 3.55p 8.58p

Trades for 26-May-2022

Time Volume / Share Price
16:35 24,562 @ 1,145.00p
16:29 2 @ 1,144.00p
16:29 23 @ 1,145.00p
16:29 2 @ 1,145.00p
16:29 2 @ 1,145.00p

Abcam Key Personnel

CEO Alan Thomas Hirzel
CFO Michael Baldock

Top of Page